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Abstract
Congenital adrenal hyperplasia is generally associated
with oligo-amenorrhea, and its presentation with
polymenorrhagia is rare. Here we present a case of an
Asian female who presented with polymenorrhagia since
menarche, increased body hair growth and enlargement
of clitoris for 7-8 years. Examination revealed a normal
Body Mass Index, moderate hirsutism, Tanner 5 breasts
and significant clitoromegaly. Serum testosterone and 17-
hydroxyprogesterone levels were elevated.
Ultrasonography revealed normal adrenal glands and
polycystic ovaries. adrenocorticotropic hormone
stimulation test uncovered borderline cortisol deficiency.
Oral dexamethasone was commenced and six months
later, she showed improvement though there was no
change in hirsutism or clitoromegaly. The case is unique
because it presented with polymenorrhagia. Also, such
phenomenally high 17-hydroxyprogesterone levels are
not expected in non-classic congenital adrenal
hyperplasia.
Keywords: Non-classic congenital Adrenal hyperplasia,
Polymenorrhagia, 17-hydroxyprogesterone.
Introduction
Oligomenorrhoea has long been known to be present in
patients with congenital adrenal hyperplasia (CAH),1 but
CAH presentation with polymenorrhagia is rare. Here we
present a case of a young woman which was presented
first at the 13th European Congress of Endocrinology,
Rotterdam. The patient presented with polymenorrhagia,
and was later diagnosed as having non-classic congenital
adrenal hyperplasia (NC-CAH). Her serum level of 17-
hydroxyprogesterone (17-OHP) was unusually high for
this variety of CAH.
Case Report
After obtaining written informed consent from the
patient for the publication of this report, we present a
case of a 23-year-old, unmarried, female medical student,
who was an Urdu-speaking Pakistani, and presented in
December 2009 with polymenorrhagia since menarche
(10 years), clitoromegaly noticed since 8 years and
hirsutism since 7 years. She reported having frequent
menstrual cycles, every 15-20 days, with a heavy flow for 5
days, along with significant dysmenorrhoea. She had
noticed some enlargement of clitoris for the preceding 8
years. Five years earlier, during anatomy classes at medical
school, she realised that this clitoral enlargement was not
normal. Subsequently, she further relaized that thick hair
growth over her body, especially around the chin area was
also abnormal. She had previously been labelled as a case
of polycystic ovarian syndrome (POCS) and had been
placed on Diane 35 (ethinyl estradiol + cyproterone
acetate) by a gynaecologist. This had resulted in some
regularisation of her menstrual cycles, but after using it
for a certain period, she stopped taking it as she noted no
improvement in the hirsutism or clitoromegaly. She had
no history of ambiguous genitalia or salt-wasting crisis at
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Table: Summary of Investigations.
Investigations Result Normal Range
Testosterone 145.8 6-82 ng/dl
Estradiol 32 0-160 pg/ml
Prolactin 21.64 4.79-23.3 ng/ml
Fasting glucose 78 65-110 mg/dl
LH (follicular) 8.35 1.1-11.6 mIU/ml
FSH (follicular) 4.89 2.8-11.3 mIU/ml
17-OH Progesterone (follicular) 170.0 0.19-1.82 ng/ml
Dehydroepiandrosterone sulfate 375 35-430 µg/dl
Thyroid Stimulating Hormone 2.54 0.17-4.05 µIU/ml
Free T4 17.51 11.5-23.0 pmol/L
Total cholesterol 107 < 200 mg/dl
Low Density Lipoprotein 58 <150 mg/dl
Triglycerides 57 35-135 mg/dl
Sodium 134.25 136-148 mmol/L
Potassium 4.07 3.6-5.0 mmol/L
Baseline cortisol 9.5 > 18 g/dl
30 min post-ACTH cortisol 15 >18 g/dl
60 min post-ACTH cortisol 17 > 18 g/dl
LH: Luteinizing hormone
FSH: Follicle-stimulating hormone
ACTH: Adrenocorticotropic hormone.
birth. Her 16-year-old Australian-born cousin was
diagnosed to have classic CAH at birth. Subsequently, he
had developed diabetes, which had been attributed to
over-treatment with steroids. There was no history of
diabetes or hormonal dysfunction relevant to her
condition in any other first-degree relatives.
On clinical examination, she had normal height (158cm),
built and weight (52kg; body mass index [BMI]: 21kg/m2).
Waist and hip circumferences were normal (72cm and
88cm respectively). Vitals were within normal ranges
(pulse: 80 beats/min, blood pressure: 110/70mmHg,
temperature: 37ºC, respiratory rate: 18 breaths/min). She
had moderate hirsutism, most marked over the chin area
(Ferriman Gallway [FG] score 20/36). She had no acne,
frontal alopecia, or increased muscularity. No abnormal
pigmentation or striae were present. Breast examination
revealed Tanner stage 5 breasts (adult stage) without any
discharge or galactorrhoea. Examination of genitalia
revealed significant clitoromegaly, with clitoral index
50mm2 [normal range: <35mm2]. Vaginal and urethral
orifices were present.
Her hormonal profile was investigated (Table) and on
the basis of all evidence possible, she was diagnosed as
a case of NC-CAH with hyper-androgenism and
subclinical adrenal insufficiency. Oral dexamethasone
0.5mg was commenced in reverse rhythm (at bed time),
with advice to double the dose in times of stress. At
follow-up after 6 months of therapy, her menstrual cycle
had regularised, serum testosterone had gone down to
2.5ng/dl (from 145.8 ng/dl) and 17-OHP had decreased
to 0.5ng/ml (from 170.0ng/ml). The patient reported no
improvement in hirsutism or clitoromegaly. She was
using local methods like waxing for hirsutism.
Subsequently, the dose of dexamethasone was
decreased to 0.25mg at bed time. For hirsutism she was
advised to continue local depilatory methods, or to
undergo laser therapy. Reconstructive plastic surgery
was advised for managing the clitoromegaly, which she
subsequently underwent in 2012.
Discussion
CAH due to 21 hydroxylase deficiency is one of the most
common autosomal recessive hereditary diseases.2-4 In
Caucasians, 1-2% of hyperandrogenism syndromes are
due to late onset NC-CAH.5,6 In NC-CAH, about 20-50% of
21-hydroxylase activity is preserved, and it usually
presents with a mild androgen excess in late childhood or
during adolescence.
In adult women, NC-CAH may manifest with signs of
virilisation, including hirsutism, acne, frontal alopecia,
clitoromegaly, male pattern hair growth or deepening of
voice. Other presentations include oligomenorrhoea and
primary amenorrhoea. Fertility issues are experienced by
13% of women with this condition.7 At times, the
condition may be subclinical. In adult males, the condition
is mainly asymptomatic, but some men may present with
adrenal rest tumour and/or fertility problems.8
CAH is an entity that must be excluded prior to making a
diagnosis of PCOS, which this patient had previously been
labelled with. PCOS can also present with hirsutism and
menstrual irregularities. Ultrasonographic appearance of
polycystic ovaries can coexist with congenital adrenal
hyperplasia,2 as in the case of our patient. This further
delayed her work-up, by gynaecologists and general
physicians, for other hormonal abnormalities responsible
for her presentation (hirsutism, clitoromegaly and
menstrual irregularity). In addition to CAH, other
conditions, such as cushing's syndrome/disease,
androgen secreting tumours, acromegaly,
hyperprolactinemia and thyroid disease, need to be
considered in the differentials of PCOS. A complete
hormonal evaluation, including her 17-OH progesterone
levels were requested for, only when the patient had been
referred to an endocrinologist following months of non-
responsiveness to treatment with Diane 35.
This case is interesting because our patient had presented
with polymenorrhagia (frequent menstrual cycles with
heavy flow). To the best of our knowledge, all cases in the
literature report oligo/amenorrhoea in association with
CAH. There was a case report describing a hirsute lady
with menorrhagia (heavy but regular menstrual cycles),
who was subsequently found to have increased 17-OH
progesterone levels.9
The other interesting aspect of our case is that this lady
presented with a phenomenally high 17-OHP level
(170.0ng/ml, unstimulated level). NC-CAH is usually
associated with mildly elevated levels of 17-OHP, often
requiring ACTH stimulation for confirmation of the
disorder.1-9 Levels of this degree are usually expected in
the classic variety of CAH, usually diagnosed at birth.
Despite such high levels of 17-OHP, our patient displayed
only borderline adrenal insufficiency, as evidenced by the
short synacthen test. The results prompted us to counsel
the patient about the importance of doubling the dose of
steroid (dexamethasone) in times of stress.
In order to ensure optimal outcomes in adult patients
with CAH, a multidisciplinary approach should be
employed at specialist centres involving endocrinologists,
gynaecologists, urologists, geneticists and
psychologists.10
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Conclusions
Prior to labelling a subject with hirsutism and menstrual
irregularity as a case of PCOS, other hormonal dysfunctions
require exclusion. Polycystic ovaries can co-exist with CAH
which is an important consideration in the differentials.
Clinicians need to be aware of the possibility of NC-CAH
presenting with unusual findings of polymenorrhagia,
and/or exceptionally high 17-OHP levels.
Written informed consent was obtained from the patient
for publication of this case report.
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